226 related articles for article (PubMed ID: 29063830)
1. Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism.
Putzbach W; Gao QQ; Patel M; van Dongen S; Haluck-Kangas A; Sarshad AA; Bartom ET; Kim KA; Scholtens DM; Hafner M; Zhao JC; Murmann AE; Peter ME
Elife; 2017 Oct; 6():. PubMed ID: 29063830
[TBL] [Abstract][Full Text] [Related]
2. Identification of DISE-inducing shRNAs by monitoring cellular responses.
Patel M; Peter ME
Cell Cycle; 2018; 17(4):506-514. PubMed ID: 29092660
[TBL] [Abstract][Full Text] [Related]
3. CD95/Fas ligand mRNA is toxic to cells.
Putzbach W; Haluck-Kangas A; Gao QQ; Sarshad AA; Bartom ET; Stults A; Qadir AS; Hafner M; Peter ME
Elife; 2018 Oct; 7():. PubMed ID: 30324908
[TBL] [Abstract][Full Text] [Related]
4. Induction of DISE in ovarian cancer cells
Murmann AE; McMahon KM; Haluck-Kangas A; Ravindran N; Patel M; Law CY; Brockway S; Wei JJ; Thaxton CS; Peter ME
Oncotarget; 2017 Oct; 8(49):84643-84658. PubMed ID: 29156673
[TBL] [Abstract][Full Text] [Related]
5. CD95/Fas ligand induced toxicity.
Haluck-Kangas A; Peter ME
Biochem Soc Trans; 2023 Feb; 51(1):21-29. PubMed ID: 36629505
[TBL] [Abstract][Full Text] [Related]
6. CD95/Fas ligand mRNA is toxic to cells through more than one mechanism.
Haluck-Kangas A; Fink M; Bartom ET; Peter ME
Mol Biomed; 2023 Apr; 4(1):11. PubMed ID: 37059938
[TBL] [Abstract][Full Text] [Related]
7. CD95 signaling in cancer treatment.
De la Rosa AJ; Gomez MA; Morales S; Padillo FJ; Muntane J
Curr Pharm Des; 2014; 20(17):2809-18. PubMed ID: 23944368
[TBL] [Abstract][Full Text] [Related]
8. Death induced by CD95 or CD95 ligand elimination.
Hadji A; Ceppi P; Murmann AE; Brockway S; Pattanayak A; Bhinder B; Hau A; De Chant S; Parimi V; Kolesza P; Richards J; Chandel N; Djaballah H; Peter ME
Cell Rep; 2014 Apr; 7(1):208-22. PubMed ID: 24656822
[TBL] [Abstract][Full Text] [Related]
9. DISE: A Seed-Dependent RNAi Off-Target Effect That Kills Cancer Cells.
Putzbach W; Gao QQ; Patel M; Haluck-Kangas A; Murmann AE; Peter ME
Trends Cancer; 2018 Jan; 4(1):10-19. PubMed ID: 29413418
[TBL] [Abstract][Full Text] [Related]
10. The role of CD95 and CD95 ligand in cancer.
Peter ME; Hadji A; Murmann AE; Brockway S; Putzbach W; Pattanayak A; Ceppi P
Cell Death Differ; 2015 Apr; 22(4):549-59. PubMed ID: 25656654
[TBL] [Abstract][Full Text] [Related]
11. CD95 and CD95L promote and protect cancer stem cells.
Ceppi P; Hadji A; Kohlhapp FJ; Pattanayak A; Hau A; Liu X; Liu H; Murmann AE; Peter ME
Nat Commun; 2014 Nov; 5():5238. PubMed ID: 25366259
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma.
Blaes J; Thomé CM; Pfenning PN; Rübmann P; Sahm F; Wick A; Bunse T; Schmenger T; Sykora J; von Deimling A; Wiestler B; Merz C; Jugold M; Haberkorn U; Abdollahi A; Debus J; Gieffers C; Kunz C; Bendszus M; Kluge M; Platten M; Fricke H; Wick W; Lemke D
Mol Cancer Res; 2018 May; 16(5):767-776. PubMed ID: 29453321
[TBL] [Abstract][Full Text] [Related]
13. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L.
Aragane Y; Kulms D; Metze D; Wilkes G; Pöppelmann B; Luger TA; Schwarz T
J Cell Biol; 1998 Jan; 140(1):171-82. PubMed ID: 9425165
[TBL] [Abstract][Full Text] [Related]
14. CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage.
Raats DA; Frenkel N; van Schelven SJ; Rinkes IH; Laoukili J; Kranenburg O
Cell Death Dis; 2017 Mar; 8(3):e2669. PubMed ID: 28300842
[TBL] [Abstract][Full Text] [Related]
15. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.
Behrens CK; Igney FH; Arnold B; Möller P; Krammer PH
J Immunol; 2001 Mar; 166(5):3240-7. PubMed ID: 11207278
[TBL] [Abstract][Full Text] [Related]
16. Screening of cell death genes with a mammalian genome-wide RNAi library.
Tsujii H; Eguchi Y; Chenchik A; Mizutani T; Yamada K; Tsujimoto Y
J Biochem; 2010 Aug; 148(2):157-70. PubMed ID: 20421362
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis.
Li JH; Kluger MS; Madge LA; Zheng L; Bothwell AL; Pober JS
Am J Pathol; 2002 Oct; 161(4):1485-95. PubMed ID: 12368221
[TBL] [Abstract][Full Text] [Related]
19. CD95 ligand expression as a mechanism of immune escape in breast cancer.
Müschen M; Moers C; Warskulat U; Even J; Niederacher D; Beckmann MW
Immunology; 2000 Jan; 99(1):69-77. PubMed ID: 10651943
[TBL] [Abstract][Full Text] [Related]
20. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
Pohl U; Wagenknecht B; Naumann U; Weller M
Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
